Literature DB >> 6843693

Inhibition of dopamine synthesis in striatal synaptosomes by lisuride: stereospecific reversal by (-)-sulpiride.

A H Tissari, L Atzori, M T Galdieri.   

Abstract

Lisuride, an ergot D2 dopamine receptor agonist inhibited dopamine synthesis in striatal synaptosomes concentration-dependently. Significant inhibition was detected at 10(-8) M, and the inhibition by 10(-4) M lisuride was 50%. The inhibitory effect of lisuride was reversed by more than 50% not only by the D1-D2 dopamine receptor blocker haloperidol but also by the D2 dopamine receptor blocker(-)-sulpiride. The effect of sulpiride was stereospecific. Under the same test conditions a similar inhibition of dopamine synthesis by apomorphine was reversed by the neuroleptics almost completely. The results suggest that there are dopamine autoreceptors controlling dopamine synthesis in synaptosomes and these receptors resemble D2 dopamine receptors according to the nomenclature of Kebabian and Calne (1979).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6843693     DOI: 10.1007/bf00649358

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum.

Authors:  L L Iversen; M A Rogawski; R J Miller
Journal:  Mol Pharmacol       Date:  1976-03       Impact factor: 4.436

Review 2.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

3.  Lergotrile and lisuride: in vivo dopaminergic agonists which do not stimulate the presynaptic dopamine autoreceptor.

Authors:  J W Kebabian; P R Kebabian
Journal:  Life Sci       Date:  1978-11-27       Impact factor: 5.037

4.  Presynaptic regulation of tyrosine hydroxylase activity in rat striatal synaptosomes by dopamine analogs.

Authors:  W G Waggoner; J McDermed; H J Leighton
Journal:  Mol Pharmacol       Date:  1980-07       Impact factor: 4.436

5.  The effect of dopamine and of apomorphine on dB-cAMP induced stimulation of synaptosomal tyrosine hydroxylase.

Authors:  B Ebstein; C Roberge; J Tabachnick; M Goldstein
Journal:  J Pharm Pharmacol       Date:  1974-12       Impact factor: 3.765

6.  Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors.

Authors:  J R Walters; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-12       Impact factor: 3.000

7.  Metoclopramide and sulpiride as selective blocking agents of pre- and postsynaptic dopamine receptors.

Authors:  T Alander; N E Andén; M Grabowska-Andén
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

8.  Effect of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brain.

Authors:  W Kehr
Journal:  Eur J Pharmacol       Date:  1977-02-07       Impact factor: 4.432

9.  Ergot alkaloids: interaction with presynaptic dopamine receptors in the neostriatum and olfactory tubercles.

Authors:  K L Marek; R H Roth
Journal:  Eur J Pharmacol       Date:  1980-03-21       Impact factor: 4.432

10.  Dopamine biosynthesis is regulated by the amine newly recaptured by dopaminergic nerve endings.

Authors:  F Cerrito; M Raiteri
Journal:  Eur J Pharmacol       Date:  1980-12-19       Impact factor: 4.432

View more
  6 in total

1.  Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function?

Authors:  C J Fowler; G Thorell; M Andersson; O Magnusson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

Review 2.  Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.

Authors:  D Clark; S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

3.  Sulpiride antagonizes the biphasic locomotor effects of quinpirole in weanling rats.

Authors:  K J Frantz; C Van Hartesveldt
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

4.  Decrease in mesencephalic dopamine autoreceptors in experimental herpes simplex encephalitis.

Authors:  M A Päivärinta; R J Marttila; J O Rinne; U K Rinne
Journal:  J Neural Transm Gen Sect       Date:  1992

5.  ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila.

Authors:  M van der Voet; B Harich; B Franke; A Schenck
Journal:  Mol Psychiatry       Date:  2015-05-12       Impact factor: 15.992

6.  Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate.

Authors:  T J Volz
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.